Bookmark and Share

This article is in the news archive.

Award of Thudichum Medal to Professor David Rubinsztein

The 2017 Thudichum Medal will be awarded to Professor David Rubinsztein from the University of Cambridge. David pioneered the strategy of autophagy upregulation as a possible therapeutic approach in various neurodegenerative diseases and has identified drugs and novel pathways that may be exploited for this objective. He has made key contributions to illuminating the relevance of autophagy defects as a disease mechanism and to the basic cell biology of this important catabolic process. He has also identified druggable pathways independent of autophagy that may be relevant to diseases caused by aggregate-prone proteins. These insights open novel avenues for developing potential therapies.

Eleven distinguished scientists and exceptional early career researchers have been honoured in the Biochemical Society’s annual Awards. 
The Awards recognize scientists for the excellence of their work and the profound impact their research has had on the scientific community and wider society. They also highlight outstanding work by early career researchers. 
Professor Anne Dell, Chair of the Awards Committee, said: “The Biochemical Society's Awards recognize scientists at all career stages, across the full spectrum of the molecular biosciences. The Award lectures in 2016 will showcase the outstanding contributions that the winners have made.” 

All of the award prize and medal lectureships carry an honorarium and all award winners will be invited to submit an article to a Society-owned publication.

Cambridge Neuroscience would like to congratulate David Rubinsztein on his success.

Posted on 28/04/2016

Further news

Go to the news index page.